Posts by Matthew F. Wszolek, MD
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
Matthew F. Wszolek, MD, and colleagues present evidence from an FDA database suggesting the use of surgical staplers and clip appliers, especially in urologic, gastrointestinal, hepatic and spleen procedures, may be more dangerous to patients than previously appreciated.
Advancing Trimodality Therapy for Bladder Cancer
Researchers explore long-term outcomes and options for bladder cancer recurrence after combination treatment using transurethral resection and chemoradiation.
Long-term Safety Profile of Salvage Cystectomy After Trimodality Therapy Seems Acceptable
Salvage cystectomy after trimodality therapy is associated with a higher rate of late complications than primary cystectomy, according to Matthew F. Wszolek, MD, and colleagues. However, the increased risk of late complications does not influence overall survival.
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy
When nonmuscle invasive bladder cancer develops after trimodality therapy for muscle invasive bladder cancer, salvage radical cystectomy isn't necessarily required, researchers have found.
Multiparametric MRI/Ultrasound Fusion Biopsy Improves Prostate Cancer Detection
Active surveillance (AS) has become an accepted way to manage prostate cancer in men at lower risk. Multiparametric MRI can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant cancers.
Dr. Matthew Wszolek is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. He finished his urology residency in 2011 and subsequently completed a fellowship in urologic oncology at MD Anderson Cancer Center. Dr. Wszolek's clinical practice focuses on the surgical treatment of urologic cancers including bladder cancer, prostate cancer, kidney cancer and testicular cancer through the use of minimally invasive (laparoscopic and robotic) and open techniques. His research interests include translational research studies in urologic cancers with a focus on bladder cancer.